Mrkhaitan Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-10-2024
- Paid Up Capital ₹ 0.10 M
as on 31-10-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 84.31%
(FY 2023)
- Ebitda 84.32%
(FY 2023)
- Net Worth -2.47%
(FY 2023)
- Total Assets 1.58%
(FY 2023)
About Mrkhaitan Pharmatech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mamta Khaitan, Rohit Khaitan, Udit Khaitan, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999CH2020PTC043011
- Company No.
043011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mrkhaitan Pharmatech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Udit Khaitan  | Director | 09-Jun-2020 | Current |
| Rohit Khaitan | Director | 09-Jun-2020 | Current |
| Mamta Khaitan | Director | 09-Jun-2020 | Current |
| Shashi Khaitan | Director | 09-Jun-2020 | Current |
Financial Performance of Mrkhaitan Pharmatech.
Mrkhaitan Pharmatech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 84.31% increase in profit. The company's net worth dipped by a decrease of 2.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mrkhaitan Pharmatech?
Unlock access to Mrkhaitan Pharmatech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sesame Foods Private LimitedActive 26 years 4 monthsRohit Khaitan and Udit Khaitan are mutual person
Khaitan Bio Energy Private LimitedActive 1 year 9 monthsMamta Khaitan and Rohit Khaitan are mutual person
- M K Properties Pvt LtdActive 44 years 3 months
Rohit Khaitan, Udit Khaitan and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mrkhaitan Pharmatech?
Mrkhaitan Pharmatech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mrkhaitan Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mrkhaitan Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
